New SEC Form D filing

Aegle Therapeutics Corp, 2026-08-28

A new SEC Form D private-offering notice from Woburn, MA, a $2,277,698 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Aegle Therapeutics Corp site↗ Verified via SEC Form D

Clinical stage biotech developing extracellular vesicle therapies derived from mesenchymal stem cells for rare dermatological diseases

Filed 2026-08-28Filed to raise $2,277,698First money in 2026-08-04Raised so far $2,277,698HQ (as filed) Woburn, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified aegletherapeutics.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source